Burkholderia cenocepacia is a member of the Burkholderia cepacia complex (Bcc), a group of Gram-negative opportunistic pathogens that cause severe lung infections in patients with cystic fibrosis and display extreme intrinsic resistance to antibiotics, including antimicrobial peptides. B. cenocepacia BCAL2157 encodes a protein homologous to SuhB, an inositol-1-monophosphatase from Escherichia coli, which was suggested to participate in posttranscriptional control of gene expression. In this work we show that a deletion of the suhB-like gene in B. cenocepacia (DsuhB Bc ) was associated with pleiotropic phenotypes. The DsuhB Bc mutant had a growth defect manifested by an almost twofold increase in the generation time relative to the parental strain. The mutant also had a general defect in protein secretion, motility and biofilm formation. Further analysis of the type II and type VI secretion systems (T2SS and T6SS) activities revealed that these secretion systems were inactive in the DsuhB Bc mutant. In addition, the mutant exhibited increased susceptibility to polymyxin B but not to aminoglycosides such as gentamicin and kanamycin. Together, our results demonstrate that suhB Bc deletion compromises general protein secretion, including the activity of the T2SS and the T6SS, and affects polymyxin B resistance, motility and biofilm formation. The pleiotropic effects observed upon suhB Bc deletion demonstrate that suhB Bc plays a critical role in the physiology of B. cenocepacia.
INTRODUCTION
Burkholderia cenocepacia is a member of the Burkholderia cepacia complex (Bcc), a group of closely related Gramnegative bacteria found ubiquitously in the environment (Coenye & Vandamme, 2003; Mahenthiralingam et al., 2005) . Bcc members have emerged as serious respiratory multidrug-resistant pathogens in patients with cystic fibrosis (CF) (Isles et al., 1984) and chronic granulomatous disease (Guide et al., 2003) . B. cenocepacia can infect and survive in amoebae, human respiratory epithelial cells and macrophages (Loutet & Valvano, 2010; Saldías & Valvano, 2009) . In macrophages, the maturation of the B. cenocepacia-containing vacuole (BcCV) is altered, as revealed by decreased acidification and delayed fusion with lysosomes (Lamothe et al., 2007) and Rab7 inactivation (Huynh et al., 2010) . Also, intracellular infection by B. cenocepacia induces Rac1 inactivation (Flannagan et al., 2012; Rosales-Reyes et al., 2012) , delayed assembly of NADPH oxidase complex onto the BcCV membrane (Keith et al., 2009; Rosales-Reyes et al., 2012) and downregulation of the autophagy pathway (Abdulrahman et al., 2011) .
The suhB gene (BCAL2157) was identified on chromosome 1 of B. cenocepacia J2315. BCAL2157 encodes a 29 kDa protein that has high sequence similarity to SuhB from E. coli (SuhB Ec ). The primary amino acid sequence of SuhB Ec has a high level of similarity to mammalian proteins of the inositol monophosphatase (IMPase) family (Matsuhisa et al., 1995) . IMPases are essential enzymes for the biosynthesis of phosphatidylinositides (PtdIns), since inositol is synthesized as myo-inositol 1-phosphate, which has to be converted to free myo-inositol by an IMPase (Eisenberg, 1967) prior to accepting the phosphatidic acid moiety from CDP-diglyceride for the generation of PtdIns (Paulus & Kennedy, 1960) . In mammals and plants, inositol phosphates and inositol phospholipids are involved in signal transduction (Munnik & Nielsen, 2011; Shewan et al., 2011) . PtdIns play a critical structural role in the cell wall architecture of mycobacteria, acting as the lipid anchor for lipoarabinomannan (Movahedzadeh et al., 2010) , and in some species lipoarabinomannan is also capped with phosphoinositol groups (Parish et al., 1997) . In Archaea, phosphoinositol is used to make membrane phospholipids and in some species phosphoinositol derivatives serve as protective, compatible solutes (Michell, 2011) . In contrast to mycobacteria and Archaea, Escherichia coli membranes may have only small amounts of PtdIns and their role in bacterial function is unclear (Kozloff et al., 1991; Michell, 2011) . suhB Ec mutants were initially isolated as suppressors of secY, rpoH (htpR) and dnaB mutations, suggesting that SuhB Ec has an effect on multiple cell processes, including protein export, the heat shock stress response, and DNA replication (Chang et al., 1991; Inada & Nakamura, 1995; Ito et al., 1983; Shiba et al., 1986) . In addition, suhB Ec mutants display a cold-sensitive phenotype and a defect in the rate of protein synthesis (Shiba et al., 1984a (Shiba et al., , 1984b . The mechanism of action of SuhB Ec remains unclear. In vitro, purified SuhB Ec has IMPase activity (Matsuhisa et al., 1995) . However, a SuhB Ec mutant protein D87N that lacks IMPase activity remains fully functional in complementing a defective suhB mutant (Chen & Roberts, 2000) . Therefore, SuhB Ec may participate in post-transcriptional control of gene expression by physically interacting with and modulating RNA III activity (Chen & Roberts, 2000; Wang et al., 2007) .
In this work, we describe that a B. cenocepacia mutant with a deletion of BCAL2157 (DsuhB Bc ) had compromised protein secretion, decreased biofilm formation and motility, and reduced resistance to polymyxin B and SDS. Surprisingly, the mutant was not impaired in its abilities to delay the phagolysosomal fusion and survive within macrophages. As in E. coli, the lack of SuhB Bc function causes pleiotropic phenotypes that together suggest a compromise of the cell envelope integrity, paving the way to target this protein for the design of novel antimicrobials.
METHODS
Antibodies and reagents. Dulbecco's modified Eagle's medium (DMEM), PBS and FBS were purchased from Wisent. Mouse monoclonal anti-FLAG (M2 clone) was from Sigma. Anti-56-2 rabbit polyclonal antibody was prepared by immunization with formalinfixed K56-2. IRDye 800-conjugated goat anti-rabbit IgG was from Rockland Immunochemicals and goat anti-rabbit conjugated to Alexa Fluor 488 and goat anti-mouse conjugated to Alexa Fluor 680 were from Invitrogen. All other chemicals were purchased from Sigma unless otherwise indicated.
Growth conditions. Bacterial strains and plasmids used in this study are described in Table 1 . Bacteria were grown in Luria-Bertani (LB) medium (Difco) at 30 or 37 uC. Trimethoprim was used at final concentrations of 50 mg ml 21 for E. coli and 100 mg ml 21 for B. cenocepacia. Tetracycline was used at final concentrations of 20 mg ml 21 for E. coli and 100 mg ml 21 for B. cenocepacia. Other antibiotics used were: 40 mg kanamycin ml 21 to maintain the helper plasmid pRK2013, and 50 mg gentamicin ml 21 to select against the E. coli donor and helper strains in triparental matings. Growth curves were determined with a Bioscreen C Automated Microbiology Growth Curve Analysis System (MTX Lab Systems). For these experiments, fresh LB medium was inoculated with aliquots of overnight cultures to give a starting OD 600 of 0.03. Doubling times were calculated on the basis of OD 600 values measured during exponential growth.
General molecular techniques. Routine DNA manipulations were performed as described by Maniatis et al. (1982) . Restriction enzymes, T4 DNA ligase and alkaline phosphatase were obtained from Roche Diagnostics. Conjugations were performed by triparental mating (Craig et al., 1989) with the pRK2013 helper plasmid (Figurski & Helinski, 1979) . DNA amplifications by PCR were done with the PTC-0200 or PTC-221 DNA engine (MJ Research) with Taq or HotStar HiFidelity DNA polymerases (Qiagen), and DNA sequencing was performed at the DNA Sequencing Facility, York University (Toronto, Canada).
Mutagenesis of B. cenocepacia K56-2 and complementing plasmid. Unmarked and non-polar deletions were performed as described previously . PCR amplifications of the 59 and 39 regions flanking BCAL2157 were performed with primers pairs 4907 (59-GCTCTTAGGCTCAACATTGCTGTCAAGG-39) and 4908 (59-GCGGATCGATGATCCACTTGAATTCG-39; ClaI site underlined), and 4909 (59-TTTTATCGATAGGCATCAACGTGT-GGGAC-39; ClaI site underlined) and 4910 (59-GCTTACTCCG-CTGCCGGATGC-39). The amplicons were digested with ClaI and ligated together into pGPI-SceI digested with SmaI, giving rise to pSM66 (BCAL2157 mutagenesis plasmid; Table 1 ). The mutant MSS40 (K56-2DsuhB Bc ; Table 1 ) was confirmed by PCR. The BCAL2157 gene was PCR-amplified using primers 5052 (59-TTTTCATATGCATCC-CATGCTCAACATTGCTGTCAAG-39; NdeI site underlined) and 5053 (59-TTTTCTAGACTCCGCTGCCGGATGCACGCG-39; XbaI site underlined). The PCR product was digested with restriction enzymes NdeI/ XbaI and cloned into similarly digested plasmid pDA17, giving rise to pSM67 encoding SuhB Bc fused with a FLAG epitope at the C terminus (Table 1) .
Protease assays. Protease assays were performed as described by Sokol et al. (1979) . The protease activity was recorded by measuring the radius of the zones of clearing surrounding the bacterial spot.
Motility assays and biofilm formation. Swarming motility was analysed on nutrient agar plates (0.5 %, w/v, agar supplemented with 0.2 %, v/v, glucose), inoculated with 2 ml of culture at OD 600 1 and incubated at 37 uC. The diameter of the motility zone was measured after 24 h. Biofilm formation was quantified as previously described (Aubert et al., 2008) . Briefly, 5 ml overnight cultures grown at 37 uC were diluted to OD 600 0.003 in LB, and triplicate 500 ml aliquots were dispensed into polystyrene tubes. Following 24 h of static incubation at 30 or 37 uC, the medium was removed and the tubes were washed gently once with distilled water. Adherent bacteria were stained with 1 % (w/v) crystal violet and washed three times with distilled water. The bound crystal violet was dissolved in 1 ml of 100 % methanol and quantified by measuring A 540 .
Electrophoretic analysis of B. cenocepacia lipopolysaccharide (LPS). LPS samples were extracted, processed and visualized by silver staining as previously described (Marolda et al., 2006) . Antibiotic sensitivity assays. Antibiotic sensitivity assays were performed as previously described (Loutet et al., 2006) . Cultures were incubated at 37 uC for 24 h in the Bioscreen C system, and the final density was determined by determining the OD 600 . All dilutions were tested in triplicate. Disk diffusion assays were used to test the susceptibility of B. cenocepacia strains to SDS. Briefly, 100-fold diluted overnight cultures in LB were spread on LB agar plates, and dry disks were applied to the surfaces. Eight microlitres of a solution containing 10 % SDS or distilled H 2 O was added to the disks in triplicate. The plates were incubated for 24 h at 37 uC, and zones of growth inhibition were measured.
Macrophage infection, lysosomal labelling and immunostaining. B. cenocepacia MH1K (Hamad et al., 2010) and MH1K-DsuhB Bc were grown overnight in LB at 37 uC with shaking. One millilitre was washed twice with PBS and resuspended in DMEM-10 % FBS. ANA-1 macrophages (Cox et al., 1989) were seeded onto 12-well tissue culture plates. Bacteria were added at an m.o.i. of 50, centrifuged for 1 min at 700 r.p.m., and incubated at 37 uC under 5 % CO 2 . At the appropriate times, infected macrophages were washed three times with PBS to remove non-adherent bacteria. Extracellular bacteria were killed by incubation with DMEM-10 % FBS-Gentamicin40 (40 mg gentamicin ml 21 ) for 30 min. Then medium was removed and macrophages were maintained in DMEM-10 % FBS-Gentamicin20 (20 mg gentamicin ml 21 ) thereafter. To enumerate intracellular bacteria, infected macrophages were lysed with 1 % Triton X-100 in PBS, and serial dilutions were made and plated on LB agar plates. To label lysosomes, macrophages were seeded onto coverslips in six-well tissue culture plates in the presence of 50 mg ml 21 Dextran-TMR 10 kDa (tetramethylrhodamine conjugate; Invitrogen) for 24 h. One hour prior to infection, macrophages were washed three times with PBS and incubated in DMEM-10 % FBS, and infected as described above. Four hours post-infection, the coverslips were washed three times with PBS, fixed with 4 % paraformaldehyde and permeabilized with 0.1 % Triton X in PBS. Cells were first incubated with the blocking solution (3 % BSA, 2 % FBS in PBS) for 30 min and with anti-B. cenocepacia polyclonal antibody for 45 min at room temperature. After washing twice with PBS, cells were subsequently incubated with goat anti-rabbit conjugated to Alexa Fluor 488 for 30 min at room temperature in the dark. Coverslips were washed three times with PBS and mounted on glass slides using fluorescent mounting medium (Dako Cytomation). Images were acquired using an Axioscope 2 (Carl Zeiss) microscope with a 6100 oil immersion objective.
Analysis of secreted proteins and western blotting. The purification of B. cenocepacia secreted proteins was done as previously described (Aubert et al., 2008 ) with a few modifications. Briefly, overnight cultures were diluted to an OD 600 0.03 in 50 ml prewarmed LB. After 4-5 h incubation at 37 uC with shaking, the cultures were adjusted to the same OD 600 , and centrifuged for 15 min at 10 000 r.p.m. at 4 uC. Culture supernatants were sterilized by filtration through a 0.22 mm pore-size filter (Millipore), and proteins were precipitated overnight at 4 uC with 10 % (v/v) TCA (final concentration). The precipitates were isolated by centrifugation at 20 000 r.p.m. for 30 min at 4 uC, and the pellets were washed with ice-cold acetone. Another centrifugation was performed at 20 000 r.p.m. for 30 min. The pellets were air-dried and then resuspended in 0.1 M sodium phosphate buffer, pH 7.0. Protein concentration was determined by Bradford assay (Bio-Rad), and aliquots containing 10 mg protein were loaded on a 16 % SDS-PAGE gel. Detection was performed with a Brilliant Blue G-Colloidal staining according to the manufacturer's recommendations (Sigma). The fusion protein (SuhB Bc -FLAG) was detected by Western blotting, using a monoclonal anti-FLAG antibody (Sigma) and the appropriate secondary antibody. Membranes were analysed by infrared imaging using an Odyssey imager (Licor).
Statistics. Statistical analysis was carried out using GraphPad Prism version 4.03 (GraphPad Software) Student's t test, with a 95 % confidence limit; a probability value of P,0.05 was considered significant. (Fig. 1a, boxed sequence) (Matsuhisa et al., 1995) . We investigated whether the suhB Bc deletion mutant (herein DsuhB Bc ) has a growth defect. At 37 u C, DsuhB Bc and DsuhB BcpDA17 (carrying the vector control) showed reduced ability to replicate during the exponential growth phase in comparison with the wild-type strain, such that the generation time was 2.5 h for K56-2-pDA17 and 4.3 h for DsuhB Bc (Fig. 1b) , but these differences disappeared at 24 h. The growth defect of DsuhB Bc was rescued by introducing pSM67, a plasmid expressing suhB Bc (Fig. 1b) . At 30 u C (Fig. 1c) , the generation times for K56-2-pDA17 and DsuhB Bc were 5 and 9.2 h, respectively. The normalized generation times of the mutant (t mutant /t wt ) at 37 and 30 u C were 1.72 and 1.84, demonstrating that the growth defect is similar, irrespective of the temperature, in contrast to reports for some suhB Ec mutant alleles, which display a cold-sensitive growth impairment (Inada & Nakamura, 1995) . We also noticed that the growth defect was more pronounced in strains grown at 37 u C under static conditions, where the generation time was 5.9 h for K56-2-pDA17 and 26 h for DsuhB Bc , respectively (T mutant /T wt 54.4; Fig. 1d ). Experiments with the LIVE/DEAD staining kit demonstrated that the slow growth rate under static conditions was not due to cell death, since culture samples had similar proportions of live and dead cells at 24 h of growth (data not shown). These results suggest that reduced oxygen availability exacerbates the growth defect phenotype of DsuhB Bc .
The B. cenocepacia DsuhB Bc mutant has a defect in protein secretion, swarming motility and biofilm formation
Since the suhB Ec gene product is involved in general protein synthesis and export (Ito et al., 1983; Shiba et al., 1984a) , we investigated whether the suhB Bc deletion could affect protein secretion in B. cenocepacia. Secreted proteins were purified from B. cenocepacia K56-2-pDA17, DsuhB BcpDA17 and DsuhB Bc -pSM67 culture supernatants as described in Methods, and the protein profiles were compared. The results show that B. cenocepacia-DsuhB BcpDA17 has an observable defect in protein secretion (Fig.  2a) , which was restored to parental levels upon complementation with pSM67 (Fig. 2a) . In addition, the SuhB Bc -FLAG fusion protein was detected only in the total cell extract and not in the secreted protein fraction (Fig. 2b) , indicating that this protein is not secreted.
The role of suhB Bc in protein secretion was further confirmed by testing specifically the activities of two secretion systems from B. cenocepacia. One of these systems is the type II secretion system (T2SS), which mediates the secretion of two zinc metalloproteases, ZmpA and ZmpB, that are responsible for the extracellular proteolytic activity in this bacterium (Kooi et al., 2005 Kooi & Sokol, 2009) . We investigated the proteolytic activity of B. cenocepacia under conditions where the activity of ZmpA and ZmpB is readily detected, which serves also to assess the functionality of the T2SS. In contrast to the parental K56-2-pDA17 strain or the complemented DsuhB Bc -pSM67 strains, DsuhB Bc or DsuhB Bc -pDA17 did not show any casein proteolytic activity (Fig. 3a) , even after 5 days of incubation at 37 u C. A similar phenotype was observed at 30 u C (data not shown). That the casein proteolytic activity is due to ZmpA and ZmpB production was confirmed by the absence of a halo in the spot inoculated with the DzmpADzmpB double mutant.
Another important secretion system is the type VI secretion system (T6SS), which is widely conserved in pathogenic and non-pathogenic Gram-negative bacteria (Cascales, 2008; Jani & Cotter, 2010; Pukatzki et al., 2009) . Previous work in our laboratory demonstrated that the B. cenocepacia T6SS is essential for virulence in vivo (Hunt et al., 2004) , and also required for the formation of actin-rich protrusions in infected macrophages (Aubert et al., 2010 (Aubert et al., , 2008 Rosales-Reyes et al., 2012) through inactivation of Rac1 (Flannagan et al., 2012; Rosales-Reyes et al., 2012) . To determine whether the suhB Bc deletion affects T6SS function, we infected macrophages with B. cenocepacia-K56-2, DsuhB Bc and DsuhB Bc -pSM67. Macrophages infected with DsuhB Bc did not show protrusions (Fig. 3b) , while protrusions were present in macrophages infected with strains K56-2 or the complemented mutant DsuhB Bc -pSM67, indicating that the T6SS is not functional in this mutant. Altogether, we conclude that suhB Bc is required for the (Table 1) were tested for casein proteolytic activity on dialysed brain heart infusion-milk agar plates (Sokol et al., 1979) . Zones of clearing around the colonies were measured after 48 h of incubation at 37 6C. Values are mean radius±SD in millimetres of two experiments performed in triplicate.
(b) ANA-1 macrophages were infected at an m.o.i. of 50 with B. cenocepacia K56-2, DsuhB Bc and DsuhB Bc -pSM67 for 6 h. Representative images are presented; macrophage protrusions are indicated by a white arrow. Uninfected macrophages were used as a negative control. Bars, 50 mm.
normal function of the T2SS and T6SS. This suggests a general defect in the assembly of multiprotein complexes in the cell envelope. To provide further evidence for this notion, we examined whether the suhB Bc gene deletion affects bacterial motility. These experiments revealed that DsuhB Bc cells are unable to swarm, but the defect can be rescued by the introduction of the complementing plasmid pSM67 (Fig. 4) . Also, the suhB Bc deletion compromised the ability of the mutant to form biofilm at 37 u C (Fig. 5a ), a defect that was even more pronounced at 30 u C (Fig. 5b) . These results agree with a report showing that a suhB transposon mutant in the unrelated B. cenocepacia strain H111 is also defective in biofilm formation (Huber et al., 2002) .
The DsuhB Bc mutant shows increased sensitivity to polymyxin B and SDS
We reasoned that the pleiotropic effects observed in DsuhB Bc could also be explained by compromised membrane biogenesis, which could be altered in the absence of suhB Ec function, and account for the observed defects in the functionality of the T2SS, T6SS, motility and biofilm formation, as the composition of membrane phospholipids is important in the formation of multiprotein complexes. Therefore, we also investigated whether the mutant has a defect in membrane permeability by assessing resistance to the cationic antimicrobial peptide polymyxin B (Loutet et al., 2006 (Loutet et al., , 2009 . Fig. 6(a) shows that B. cenocepacia K56-2-pDA17 is highly resistant to polymyxin B (MIC 50 .1024 mg ml
21
), while DsuhB Bc or DsuhB Bc -pDA17 (containing the vector control) showed reduced resistance to polymyxin B (MIC 50 ¡512 mg ml
). Resistance to polymyxin B was restored to parental levels upon complementation with pSM67 (MIC 50 .1024 mg ml
). Furthermore, DsuhB Bc showed increased sensitivity to the anionic detergent SDS (Fig. 6b) , which was rescued by the introduction of pSM67 (Fig. 6b) . Together, increased susceptibility to polymyxin B and SDS suggests that DsuhB Bc has an altered outer membrane. This alteration is not due to gross defects in the LPS of the mutant compared with the parental strain (data not shown) and its mechanism is not clear. B. cenocepacia also exhibits high resistance to aminoglycosides (Chen & Roberts, 2000; Hamad et al., 2010; Waters & Ratjen, 2006) , which depends for the most part on efflux pumps (Buroni et al., 2009; Hamad et al., 2010) . DsuhB Bc does not show any significant differences in resistance to kanamycin or gentamicin in comparison with the parental strain (Fig.  6c, d ). These results, together with the observed defects in the T2SS and T6SS functionality (Fig. 3a, b) , further suggest that the outer-membrane organization or stability in DsuhB Bc is compromised. suhB Bc does not affect the ability of B. cenocepacia to infect and survive in macrophages
The ability of B. cenocepacia to infect and persist in macrophages is associated with delayed phagolysosomal fusion (Huynh et al., 2010; Keith et al., 2009; Lamothe et al., 2007; Rosales-Reyes et al., 2012) . To identify whether suhB Bc plays a role in the ability of B. cenocepacia to survive intracellularly we deleted the suhB Bc gene in the MH1K strain, an isogenic derivative of strain K56-2 that exhibits high susceptibility to gentamicin (Hamad et al., 2010) . A gentamicin protection assay was performed on infected macrophages with MH1K and MH1K-DsuhB Bc . Infected cells were stained with an anti-B. cenocepacia and anti-LAMP-1 (marker for late endosomal and lysosomal compartments) to identify whether the suhB Bc deletion causes a defect in trafficking resulting in loss of the phagolysosomal fusion arrest and therefore a higher number of BcCVs acquiring LAMP-1. The results show that DsuhB Bc does not mediate an increased LAMP-1 association with BcCVs (Fig. 7a) . To confirm this result, we infected macrophages preloaded with TMR-Dextran to quantify the lysosomal fusion at BcCV. The results show that the suhB Bc deletion does not affect the ability of B. cenocepacia to delay the lysosomal fusion at BcCV (Fig. 7b) . Finally, we performed a conventional gentamicin protection assay to quantify the intracellular infection. The results show that both MH1K and MH1KDsuhB Bc infect and survive in macrophages (Fig.  7c) , indicating that the suhB Bc gene deletion does not alter the ability of intracellular B. cenocepacia to delay the phagolysosomal fusion and its survival in macrophages.
Concluding remarks
Our results show that the suhB Bc deletion causes dramatic effects on the function of protein secretion systems, a growth defect and also various defects in motility and biofilm formation. Given the level of amino acid identity in the SuhB proteins from E. coli and B. cenocepacia it is possible that SuhB Bc works in conjunction with RNA polymerase III and affects protein expression of multiple genes and gene products, as described for the E. coli counterpart (Wang et al., 2007) . However, the cold-sensitive phenotype described in E. coli suhB mutants is not evident in DsuhB Bc , suggesting that despite the similarities between the E. coli and Burkholderia proteins, their cellular functions may not be identical. B. cenocepacia possesses novel lipids and also cholesterol-like molecules in its cell envelope (González-Silva et al., 2011; Schmerk et al., 2011) . It is therefore possible that SuhB Bc may be involved in the synthesis of minor PtdnINs that play a key role in membrane organization. The results of macrophage infections indicate that the loss of SuhB Bc affects the T6SS-mediated actin rearrangements but does not impair intracellular survival and the arrested maturation of the BcCV, both of which are T6SS-independent traits. At present, we cannot rule out that the availability of myo-inositol in the host cell may provide intracellular B. cenocepacia with the product of the IMPase reaction and chemically rescue the loss of SuhB Bc . Further experiments are under way in our laboratory to investigate the specific mechanism of SuhB Bc function and determine whether inhibitory strategies may be an alternative to reduce at least in part the extreme antimicrobial resistance burden of B. cenocepacia.
